Wilmington Savings Fund Society’s Ligand Pharmaceuticals LGND Stock Holding History

Wilmington Savings Fund Society’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.7K	Hold	170	–	–	﹤0.01%	881
2026 Q1	$33.9K	Sell	170 -20	-11%	-$3.96K	﹤0.01%	956
2025 Q4	$35.9K	Sell	190 -892	-82%	-$171K	﹤0.01%	950
2025 Q3	$192K	Sell	1,082 -100	-8%	-$14.9K	﹤0.01%	602
2025 Q2	$134K	Hold	1,182	–	–	﹤0.01%	933
2025 Q1	$124K	Sell	1,182 -618	-34%	-$69.9K	﹤0.01%	940
2024 Q4	$193K	Hold	1,800	–	–	﹤0.01%	841
2024 Q3	$180K	Buy	+1,800	New	+$181K	﹤0.01%	854

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wilmington Savings Fund Society's LGND Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 170 shares worth $53.7K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Wilmington Savings Fund Society first reported a position in LGND in Q3 2024 and has held it in 8 quarters since. The position peaked at $193K in Q4 2024. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Wilmington Savings Fund Society held 170 shares of Ligand Pharmaceuticals worth $53.7K as of Q2 2026.
Wilmington Savings Fund Society left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
Ligand Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #881 holding.
Wilmington Savings Fund Society first reported a position in Ligand Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's Ligand Pharmaceuticals position peaked at $193K in Q4 2024.
414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.